| 國立交通大學 |
2014-12-08T15:06:43Z |
Dip Pen Nanolithography of Conductive Silver Traces
|
Hung, Sheng-Chun; Nafday, Omkar A.; Haaheim, Jason R.; Ren, Fan; Chi, G. C.; Pearton, Stephen J. |
| 國立臺灣大學 |
2009 |
DIP-2泛素化修飾抑癌蛋白PML之降解機制探討
|
江政達; Chiang, Cheng-Ta |
| 亞洲大學 |
2019-12 |
Dipeptide IF prevents the effects of hypertension-induced Alzheimer's disease on long-term memory in the cortex of spontaneously hypertensive rats
|
Ch, Yung-Ming;Chang, Yung-Ming;Kum, K. Ashok;Kumar, K. Ashok;Ju, Da-Tong;Ju, Da-Tong;Tsung-Jung, H;Ho, Tsung-Jung;Mahalaksh, B.;Mahalakshmi, B.;Lin, Wan-Teng;Lin, Wan-Teng;Hsua, Cecilia;Day, Cecilia Hsuan;Pa, V. Vijaya;Padma, V. Vijaya;Li, Po-Hsiang;Liao, Po-Hsiang;黃志揚;Huang, Chih-Yang |
| 國立臺北護理健康大學 |
2013-12 |
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
|
Mackenzie, Ian R.; Arzberger, Thomas; Kremmer, Elisabeth; Troost, Dirk; Lorenzl, Stefan; Mori, Kohji; Weng, Shih-Ming; Haass, Christian; Kretzschmar, Hans A.; Edbauer, Dieter; Neumann, Manuela |
| 國家衛生研究院 |
2007-05 |
Dipeptidyl peptidase 8/9-like activity in human leukocytes
|
Maes, MB; Dubois, V; Brandt, I; Lambeir, AM; Van der Veken, P; Augustyns, K; Cheng, JD; Chen, X; Scharpe, S; De Meester, I |
| 亞洲大學 |
2016 |
Dipeptidyl Peptidase-4 (DPP-4) Enzyme Inhibitor Study by In Silico Analysis: Molecular Docking, Pharmacophore Generation and Molecular Dynamics Simulation in Treatment of Type-2 Diabetes
|
Meduru, Harika |
| 國家衛生研究院 |
2016-08 |
Dipeptidyl peptidase-4 inhibitor LAF-237 improves glucose tolerance and expends graft beta cell mass in diabetic mice transplanted with a sufficient number of islets
|
Juang, JH;Kuo, CH;Chen, CY;Kao, CW;Chen, CT |
| 中山醫學大學 |
2020 |
Dipeptidyl peptidase-4 inhibitor treatment could decrease chronic rhinosinusitis in diabetic patients
|
Li, SY; Chen, HH; Lai, CC; Lin, CL; Kao, CH |
| 中山醫學大學 |
2020 |
Dipeptidyl peptidase-4 inhibitor treatment could decreaseKlebsiella pneumoniaepneumonia in patients with type 2 diabetes
|
Chen, HH; Chen, CC; Ho, CW; Hsieh, MC; Hsu, SP; Lin, CL; Kao, CH |
| 國立成功大學 |
2018-09 |
Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study
|
Hou;Wen-Hsuan;Chang;Kai-Cheng;Li;Chung-Yi;Ou;Huang-Tz |
| 臺大學術典藏 |
2018-09-10T15:32:45Z |
Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients
|
Chia-Hsuin Chang;Jou-Wei Lin;Shu-Ting Chen;Mei-Shu Lai;Lee-Ming Chuang;Yi-Cheng Chang; CHIA-HSUIN CHANG; YI-CHENG CHANG; LEE-MING CHUANG |
| 臺大學術典藏 |
2019-05-18T08:00:08Z |
Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients
|
Mei-Shu Lai;Shu-Ting Chen;YI-CHENG CHANG;LEE-MING CHUANG;JOU-WEI LIN;CHIA-HSUIN CHANG; CHIA-HSUIN CHANG; JOU-WEI LIN; Shu-Ting Chen; Mei-Shu Lai; LEE-MING CHUANG; YI-CHENG CHANG |
| 臺大學術典藏 |
2016 |
Dipeptidyl peptidase-4 inhibitor use is not associated with acute pancreatitis in high-risk type 2 diabetic patients a nationwide cohort study
|
Chang, Chia-Hsuin;Lin, Jou-Wei;Chen, Shu-Ting;Lai, Mei-Shu;Chuang, Lee-Ming;Chang, Yi-Cheng; CHIA-HSUIN CHANG; YI-CHENG CHANG; JOU-WEI LIN; LEE-MING CHUANG; Chen, Shu-Ting; Lai, Mei-Shu; RAY-E CHANG |
| 臺大學術典藏 |
2020-10-15T03:57:50Z |
Dipeptidyl peptidase-4 inhibitor use is not associated with acute pancreatitis in high-risk type 2 diabetic patients a nationwide cohort study
|
CHIA-HSUIN CHANG; Lin J.-W.; Chen S.-T.; Lai M.-S.; Chuang L.-M.; Chang Y.-C. |
| 臺大學術典藏 |
2022-03-10T05:59:31Z |
Dipeptidyl peptidase-4 inhibitor use is not associated with acute pancreatitis in high-risk type 2 diabetic patients a nationwide cohort study
|
Chang C.-H.; Lin J.-W.; Chen S.-T.; Lai M.-S.; Chuang L.-M.; YI-CHENG CHANG |
| 國立臺灣大學 |
2016 |
Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study
|
Chang, Chia-Hsuin; Lin, Jou-Wei; Chen, Shu-Ting; Lai, Mei-Shu; Chuang, Lee-Ming; Chang, Yi-Cheng; 賴美淑; 張家勳; 莊立民; 張以承; 林昭維 |
| 臺大學術典藏 |
2019-04-26T09:13:42Z |
Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study
|
Chia-Hsuin Chang;Jou-Wei Lin;Chen, Shu-Ting;Lai, Mei-Shu;Lee-Ming Chuang;Yi-Cheng Chang; CHIA-HSUIN CHANG; JOU-WEI LIN; Chen, Shu-Ting; Lai, Mei-Shu; LEE-MING CHUANG; YI-CHENG CHANG |
| 國立成功大學 |
2016-09 |
Dipeptidyl peptidase-4 inhibitor use is not associated with elevated risk of severe joint pain in patients with type 2 diabetes: a population-based cohort study
|
Hou, Wen-Hsuan; Chang, Kai-Cheng; Li, Chung-Yi; Ou, Huang-Tz |
| 國家衛生研究院 |
2017-03 |
Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure
|
Ou, SM;Chen, HT;Kuo, SC;Chen, TJ;Shih, CJ;Chen, YT |
| 國家衛生研究院 |
2021-01-10 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: A nationwide population-based cohort study in Taiwan
|
Yen, FS;Wei, JCC;Yip, HT;Hwu, CM;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2021 |
Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan
|
Yen, FS; Wei, JCC; Yip, HT; Hwu, CM; Hou, MC; Hsu, CC |
| 中國醫藥大學 |
2014-07-16 |
Dipeptidyl Peptidase-4 inhibitor類合併使用其他口服降血糖藥物與糖尿病患者發生低血糖症風險之相關性研究
|
鄭宇傑;Yu-Chieh Cheng |
| 國立臺灣大學 |
2007 |
Dipeptidyl Peptidase-Iv Inhibitors: An Evolving Treatment for Type 2 Diabetes from the Incretin Concept
|
錢瑤珍; 莊立民; CHYAN, YAU-JAN; CHUANG, LEE-MING |
| 中山醫學大學 |
2020 |
DIPEPTIDYL-PEPTIDASE 4 INHIBITORS DID NOT IMPROVE RENAL ENDPOINTS IN ADVANCED DIABETIC KIDNEY DISEASE
|
Kornelius, E; Huang, CN; Lo, SC; Wang, YH; Yang, YS |
| 中國醫藥大學 |
2012-05 |
Dipeptidyl-peptidase IV inhibitory activity of peptides derived from tuna cooking juice hydrolysates
|
黃士禮(Huang, Shih-Li);饒家麟(Jao, Chia-Ling);何潔攀(Ho, Kit-Pan);徐國強(Hsu, Kuo-Chiang)* |
